Danaher

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Danaher and other ETFs, options, and stocks.

About DHR

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. 

CEO
Rainer M. Blair
CEORainer M. Blair
Employees
63,000
Employees63,000
Headquarters
Washington, District of Columbia
HeadquartersWashington, District of Columbia
Founded
1984
Founded1984
Employees
63,000
Employees63,000

DHR Key Statistics

Market cap
165.15B
Market cap165.15B
Price-Earnings ratio
43.59
Price-Earnings ratio43.59
Dividend yield
0.46%
Dividend yield0.46%
Average volume
3.97M
Average volume3.97M
High today
$230.81
High today$230.81
Low today
$225.00
Low today$225.00
Open price
$226.96
Open price$226.96
Volume
7.03M
Volume7.03M
52 Week high
$281.70
52 Week high$281.70
52 Week low
$222.53
52 Week low$222.53

DHR News

Seeking Alpha 2d
Danaher, Cryoport, Sartorius win Buy as Guggenheim expands bioprocessing coverage

Guggenheim Partners expanded its coverage on the bioprocessing industry on Thursday, granting Buy recommendations for Danaher (NYSE:DHR), Cryoport (NASDAQ:CYRX)...

Danaher, Cryoport, Sartorius win Buy as Guggenheim expands bioprocessing coverage
TipRanks 3d
Danaher initiated with a Buy at Guggenheim

Guggenheim analyst Subbu Nambi initiated coverage of Danaher (DHR) with a Buy rating and $275 price target as the firm expands its bioprocessing tools coverage....

Analyst ratings

83%

of 29 ratings
Buy
82.8%
Hold
17.2%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.